Drug-Resistant Bacterial Infections and Alternative Therapies
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Microbiology in Human Health and Disease".
Deadline for manuscript submissions: closed (30 September 2024) | Viewed by 18622
Special Issue Editor
Interests: antibiotic-resistance; bacterial infections; drug discovery; biofilms; alternative therapeutic agents; combinational therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues
Antibiotic resistance has emerged as a global healthcare challenge and therapeutic options for treating antibiotic-resistant infections are shrinking. Antibiotic resistance limits the effectiveness of existing antibiotics and complicates the treatment of infectious diseases. Addressing antibiotic resistance requires a multifaceted approach, and the development of novel alternatives to antibiotics is crucial to combat resistance, which includes the discovery/development of novel antibacterial agents, phages, enzybiotics, plant extracts, antibacterial nanoparticles, etc. These antibacterial agents may offer potential benefits in treating infections when used alone or in combination with available therapeutic options.
This Special Issue is focused on publishing primary research and review articles that explore novel therapeutic agents which could be used as an alternative to conventional antibiotics in managing drug-resistant bacterial infections. We welcome articles focused on topics including, but not limited to:
- Applications of phages as therapeutic agents and their synergy with antibiotics;
- Applications of enzybiotics as therapeutic agents and their synergy with antibiotics;
- Plant-based antibacterial agents;
- Antibacterial nanoparticle- and alternative agent-loaded delivery systems;
- Drug discovery and development of new antibacterial agents;
- Treatment of biofilms and biofilm-associated infections with alternative agents.
Dr. Vijay Singh Gondil
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- alternative agents
- antibiotics
- phages
- endolysins
- phytochemicals
- drug discovery
- nanoparticles
- biofilms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.